Plus, AstraZeneca said its coronavirus vaccine developed with Oxford University showed a promising immune response in an early study, airline stocks are down after TSA said air travel is down for the first time since April, and Amazon is up after two bullish upgrades.
Read MoreBuy Price: $5.00 or better Sell Price: TradersPro Sell Signal Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The company operates in two segments, Diagnostic Substances and Therapeutic Development Programs.
Read MorePlus, jobless claims came in higher than 1 million for the seventeenth week in a row, security experts warned Russian hackers are trying to steal COVID-19 vaccine research, Morgan Stanley reported better-than-expected earnings, and Tesla shares are down after a report that its vehicle registrations were down by nearly half in the second quarter.
Read MorePlus, Goldman Sachs reported blow-out earnings results, Walmart announced it will now require shoppers to wear masks at all of its stores, Apple won an appeal against the European Commission, and Zoom Communications is getting into hardware.
Read MoreBuy Target: $24.50 or better Sell Target: TradersPro Sell Signal TG Therapeutics, Inc., a biopharmaceutical company, engages in developing and delivering medicines for patients with chronic lymphocytic leukemia (CLL), non-Hodgkin’s Lymphoma (NHL), and multiple sclerosis (MS). The company develops a robust B-cell directed research and development platform for identification of key B-cell pathways of interest […]
Read MorePlus, Tesla shares are up amid speculation that the electric vehicle maker will soon join the S&P 500, chip maker Analog Devices is buying Maxim Integrated, RTW Retailwinds has declared bankruptcy, and PepsiCo reported earnings.
Read MorePlus, the U.S. reported another record jump in new coronavirus cases, Gilead released positive results from an analysis of its remdesivir treatment in patients severely ill with COVID-19, United reached an agreement with its pilots union, and a top Apple analyst issued a new prediction.
Read MoreBuy Price: $8.00 or better Sell Price: TradersPro Sell Signal Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary. The company’s promoted products include M-72, a methylphenidate hydrochloride extended-release tablet to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER, an amantadine […]
Read MorePlus, jobless claims came in above 1 million for the 16th straight week, the U.S. surpassed 3 million confirmed coronavirus cases, United Airlines warned 36,000 employees of possible furloughs, and Walgreens reported disappointing earnings.
Read MorePlus, Regeneron said it has signed a $450 million contract with the U.S. to procure up to 1.3 million doses of its coronavirus antibody treatment, the White House is pushing Congress to pass a new stimulus bill by early August, Carnival shares are down after it canceled more cruises, and Palantir just filed to go public.
Read MorePlus, Goldman Sachs and Citi issued new forecasts for the market and economy, Regeneron is beginning a phase 3 trial of its coronavirus antibody cocktail, the FDA issued emergency use authorization for Becton Dickinson’s 15-minute coronavirus test, and Uber has officially agreed to acquire Postmates.
Read MoreBuy Price: $13.00 or better Sell Price: TradersPro Sell Signal Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company’s lead product candidate includes Auryxia, a ferric citrate to control the serum phosphorus levels in adult patients with chronic kidney disease (CKD), on […]
Read MoreIn the last couple of weeks the market seems to have been trying to resolve the contradiction of the world we’re in right now. State governments began lifting COVID-19-induced restrictions in order to restart economic activity, which gave investors reason to start being optimistic again, but even as we are seeing progress in terms of […]
Read MoreBuy Price: $21.00 or better Sell Price: TradersPro Sell Signal TG Therapeutics, Inc., a biopharmaceutical company, engages in developing and delivering medicines for patients with chronic lymphocytic leukemia (CLL), non-Hodgkin’s Lymphoma (NHL), and multiple sclerosis (MS). The company develops a robust B-cell directed research and development platform for identification of key B-cell pathways of interest […]
Read MorePlus, the U.S. reported a record number of new confirmed coronavirus cases, the FAA and Boeing completed the test flights of the 737 Max, Tesla is up after saying it delivered 90,650 vehicles in the second quarter, and PG&E shares are up after the utility emerges from bankruptcy.
Read More